

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.85678663 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.44664163 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.27145608 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.95433478 |
| 5 | V(D)J recombination (GO:0033151) | 5.45785137 |
| 6 | synaptic vesicle maturation (GO:0016188) | 5.26378183 |
| 7 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.24408476 |
| 8 | leukocyte aggregation (GO:0070486) | 4.91111712 |
| 9 | locomotory exploration behavior (GO:0035641) | 4.82890283 |
| 10 | signal complex assembly (GO:0007172) | 4.79544893 |
| 11 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.75274820 |
| 12 | detection of bacterium (GO:0016045) | 4.70573949 |
| 13 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.70434481 |
| 14 | detection of other organism (GO:0098543) | 4.57697509 |
| 15 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.57107024 |
| 16 | T cell migration (GO:0072678) | 4.53466128 |
| 17 | neutrophil activation involved in immune response (GO:0002283) | 4.52516623 |
| 18 | tolerance induction (GO:0002507) | 4.47377602 |
| 19 | positive regulation by symbiont of host defense response (GO:0052509) | 4.42772197 |
| 20 | modulation by symbiont of host defense response (GO:0052031) | 4.42772197 |
| 21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.42772197 |
| 22 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.42772197 |
| 23 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.42772197 |
| 24 | modulation by symbiont of host immune response (GO:0052553) | 4.42772197 |
| 25 | synaptic vesicle exocytosis (GO:0016079) | 4.37754001 |
| 26 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.37563617 |
| 27 | vocalization behavior (GO:0071625) | 4.26521339 |
| 28 | immunoglobulin mediated immune response (GO:0016064) | 4.23106241 |
| 29 | positive T cell selection (GO:0043368) | 4.22777194 |
| 30 | layer formation in cerebral cortex (GO:0021819) | 4.21211185 |
| 31 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.21154255 |
| 32 | regulation of T cell tolerance induction (GO:0002664) | 4.19689193 |
| 33 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.17883161 |
| 34 | B cell receptor signaling pathway (GO:0050853) | 4.14410179 |
| 35 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.11388604 |
| 36 | negative regulation of cell killing (GO:0031342) | 4.11388604 |
| 37 | glutamate secretion (GO:0014047) | 4.09780244 |
| 38 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.09669789 |
| 39 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 4.07302774 |
| 40 | cellular extravasation (GO:0045123) | 4.06729913 |
| 41 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.01406324 |
| 42 | exploration behavior (GO:0035640) | 4.00647542 |
| 43 | negative regulation of T cell mediated immunity (GO:0002710) | 3.96123478 |
| 44 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.92123436 |
| 45 | positive regulation of B cell differentiation (GO:0045579) | 3.90607294 |
| 46 | positive regulation of synapse maturation (GO:0090129) | 3.89701321 |
| 47 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.87048167 |
| 48 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.80430556 |
| 49 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.79861646 |
| 50 | negative regulation of phagocytosis (GO:0050765) | 3.78577074 |
| 51 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.78458283 |
| 52 | cellular response to type I interferon (GO:0071357) | 3.78017668 |
| 53 | type I interferon signaling pathway (GO:0060337) | 3.78017668 |
| 54 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.77824370 |
| 55 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.76487018 |
| 56 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.74732365 |
| 57 | regulation of B cell differentiation (GO:0045577) | 3.74627759 |
| 58 | response to type I interferon (GO:0034340) | 3.73762754 |
| 59 | negative T cell selection (GO:0043383) | 3.71590152 |
| 60 | regulation of regulatory T cell differentiation (GO:0045589) | 3.69283319 |
| 61 | regulation of tolerance induction (GO:0002643) | 3.68208756 |
| 62 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.67882373 |
| 63 | protein localization to synapse (GO:0035418) | 3.65756286 |
| 64 | respiratory burst (GO:0045730) | 3.64665757 |
| 65 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.60851066 |
| 66 | macrophage activation involved in immune response (GO:0002281) | 3.60471289 |
| 67 | neutrophil activation (GO:0042119) | 3.53139635 |
| 68 | sodium ion export (GO:0071436) | 3.50321191 |
| 69 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.48281382 |
| 70 | dendritic spine morphogenesis (GO:0060997) | 3.48031737 |
| 71 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.47882906 |
| 72 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.47569382 |
| 73 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.46970714 |
| 74 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.46970714 |
| 75 | neurotransmitter secretion (GO:0007269) | 3.46622570 |
| 76 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.42900193 |
| 77 | T cell selection (GO:0045058) | 3.40718599 |
| 78 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.38959874 |
| 79 | B cell mediated immunity (GO:0019724) | 3.38176267 |
| 80 | regulation of gamma-delta T cell activation (GO:0046643) | 3.37236324 |
| 81 | neutrophil mediated immunity (GO:0002446) | 3.36585111 |
| 82 | detection of external biotic stimulus (GO:0098581) | 3.34752183 |
| 83 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.33394776 |
| 84 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.31901152 |
| 85 | myeloid dendritic cell differentiation (GO:0043011) | 3.29879566 |
| 86 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.27851266 |
| 87 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.27275306 |
| 88 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.26549863 |
| 89 | T cell receptor signaling pathway (GO:0050852) | 3.25816916 |
| 90 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.24936694 |
| 91 | regulation of synaptic vesicle transport (GO:1902803) | 3.24581896 |
| 92 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.23772501 |
| 93 | myeloid dendritic cell activation (GO:0001773) | 3.20603298 |
| 94 | positive regulation of tolerance induction (GO:0002645) | 3.20110281 |
| 95 | NIK/NF-kappaB signaling (GO:0038061) | 3.19188750 |
| 96 | negative regulation of interleukin-12 production (GO:0032695) | 3.18615333 |
| 97 | activation of protein kinase A activity (GO:0034199) | 3.17886368 |
| 98 | positive regulation of humoral immune response (GO:0002922) | 3.16128802 |
| 99 | myeloid cell activation involved in immune response (GO:0002275) | 3.15308143 |
| 100 | granulocyte activation (GO:0036230) | 3.15276537 |
| 101 | response to peptidoglycan (GO:0032494) | 3.14685325 |
| 102 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.14274365 |
| 103 | gamma-aminobutyric acid transport (GO:0015812) | 3.14242152 |
| 104 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.14094971 |
| 105 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.11985759 |
| 106 | regulation of synapse structural plasticity (GO:0051823) | 3.11064066 |
| 107 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.10787631 |
| 108 | T cell homeostasis (GO:0043029) | 3.10548071 |
| 109 | clathrin coat assembly (GO:0048268) | 3.09712167 |
| 110 | neuron cell-cell adhesion (GO:0007158) | 3.08956244 |
| 111 | mast cell degranulation (GO:0043303) | 3.08661950 |
| 112 | mast cell activation involved in immune response (GO:0002279) | 3.08661950 |
| 113 | lymphocyte homeostasis (GO:0002260) | 3.08463474 |
| 114 | cellular potassium ion homeostasis (GO:0030007) | 3.08358315 |
| 115 | regulation of ARF GTPase activity (GO:0032312) | 3.06172161 |
| 116 | positive regulation of membrane potential (GO:0045838) | 3.05465085 |
| 117 | negative regulation of microtubule polymerization (GO:0031115) | 3.05301143 |
| 118 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.03630272 |
| 119 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.03470466 |
| 120 | leukocyte degranulation (GO:0043299) | 3.03303781 |
| 121 | synaptic vesicle endocytosis (GO:0048488) | 3.03065360 |
| 122 | lymphocyte migration (GO:0072676) | 3.03017076 |
| 123 | long-term memory (GO:0007616) | 3.02808807 |
| 124 | synaptic transmission, glutamatergic (GO:0035249) | 3.02381848 |
| 125 | glutamate receptor signaling pathway (GO:0007215) | 3.01502156 |
| 126 | response to muramyl dipeptide (GO:0032495) | 3.01041240 |
| 127 | B cell homeostasis (GO:0001782) | 3.00522083 |
| 128 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.98616697 |
| 129 | regulation of synaptic plasticity (GO:0048167) | 2.96298919 |
| 130 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.96071048 |
| 131 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.95771238 |
| 132 | response to host immune response (GO:0052572) | 2.95771238 |
| 133 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.95753657 |
| 134 | negative thymic T cell selection (GO:0045060) | 2.95426285 |
| 135 | response to interleukin-15 (GO:0070672) | 2.94695260 |
| 136 | neuromuscular process controlling balance (GO:0050885) | 2.93927508 |
| 137 | defense response to protozoan (GO:0042832) | 2.93338215 |
| 138 | activated T cell proliferation (GO:0050798) | 2.89839762 |
| 139 | myeloid leukocyte mediated immunity (GO:0002444) | 2.89201285 |
| 140 | positive regulation of granulocyte differentiation (GO:0030854) | 2.89005929 |
| 141 | negative regulation of innate immune response (GO:0045824) | 2.88791633 |
| 142 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.88593201 |
| 143 | mitochondrion transport along microtubule (GO:0047497) | 2.88593201 |
| 144 | regulation of antigen processing and presentation (GO:0002577) | 2.88181871 |
| 145 | detection of biotic stimulus (GO:0009595) | 2.88157710 |
| 146 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.87788787 |
| 147 | regulation of Rap GTPase activity (GO:0032317) | 2.87441958 |
| 148 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.87135060 |
| 149 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.83968528 |
| 150 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.82949029 |
| 151 | Peyers patch development (GO:0048541) | 2.82949029 |
| 152 | positive regulation of Rap GTPase activity (GO:0032854) | 2.81692628 |
| 153 | neuron-neuron synaptic transmission (GO:0007270) | 2.80522588 |
| 154 | thymic T cell selection (GO:0045061) | 2.78660754 |
| 155 | nerve growth factor signaling pathway (GO:0038180) | 2.78005077 |
| 156 | cerebellar granule cell differentiation (GO:0021707) | 2.77406637 |
| 157 | regulation of ARF protein signal transduction (GO:0032012) | 2.72850920 |
| 158 | regulation of postsynaptic membrane potential (GO:0060078) | 2.71966237 |
| 159 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.69981703 |
| 160 | proline transport (GO:0015824) | 2.69189794 |
| 161 | dopamine receptor signaling pathway (GO:0007212) | 2.68963937 |
| 162 | regulation of dendritic spine development (GO:0060998) | 2.68661354 |
| 163 | regulation of defense response to virus by virus (GO:0050690) | 2.62381015 |
| 164 | positive regulation of dendritic spine development (GO:0060999) | 2.60672510 |
| 165 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.60170622 |
| 166 | neuronal action potential propagation (GO:0019227) | 2.59284080 |
| 167 | mast cell activation (GO:0045576) | 2.57671510 |
| 168 | regulation of synapse maturation (GO:0090128) | 2.57664762 |
| 169 | positive thymic T cell selection (GO:0045059) | 2.57342978 |
| 170 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.55296534 |
| 171 | T cell costimulation (GO:0031295) | 2.54181692 |
| 172 | protein-DNA complex disassembly (GO:0032986) | 2.53850232 |
| 173 | nucleosome disassembly (GO:0006337) | 2.53850232 |
| 174 | DNA unwinding involved in DNA replication (GO:0006268) | 2.53765120 |
| 175 | establishment of mitochondrion localization (GO:0051654) | 2.53006562 |
| 176 | auditory behavior (GO:0031223) | 2.52764313 |
| 177 | histone H4-K12 acetylation (GO:0043983) | 2.52118820 |
| 178 | cellular response to interleukin-15 (GO:0071350) | 2.51148298 |
| 179 | lymphocyte costimulation (GO:0031294) | 2.50601169 |
| 180 | regulation of neurotransmitter levels (GO:0001505) | 2.50056037 |
| 181 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.49786767 |
| 182 | negative regulation of RNA splicing (GO:0033119) | 2.48075917 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.24803773 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 4.13709179 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.68602058 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.64078666 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.30111091 |
| 6 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.21708979 |
| 7 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.20733974 |
| 8 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 3.14640325 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.10226147 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.06369214 |
| 11 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.94047893 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.92397518 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.91997000 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.91338344 |
| 15 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.74809405 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.74045377 |
| 17 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.68180920 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.66979719 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.66300427 |
| 20 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.58542904 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.55414558 |
| 22 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.48851974 |
| 23 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.47077820 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.44681886 |
| 25 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.42230976 |
| 26 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.35857212 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.34365952 |
| 28 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.33144811 |
| 29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.32092964 |
| 30 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.30308858 |
| 31 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.25517912 |
| 32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.25389432 |
| 33 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 2.17575575 |
| 34 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 2.17349024 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.16447918 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.13323739 |
| 37 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 2.10885411 |
| 38 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.10330813 |
| 39 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.10238998 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.03040634 |
| 41 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.00095031 |
| 42 | UTX_26944678_Chip-Seq_JUKART_Human | 1.98060182 |
| 43 | KDM2B_26808549_Chip-Seq_K562_Human | 1.93061316 |
| 44 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.90995484 |
| 45 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.90605759 |
| 46 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.85686150 |
| 47 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.84875094 |
| 48 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.82769764 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81531134 |
| 50 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.79963412 |
| 51 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.75777058 |
| 52 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.74987739 |
| 53 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.74827054 |
| 54 | MAF_26560356_Chip-Seq_TH1_Human | 1.74190796 |
| 55 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.72099343 |
| 56 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.68497351 |
| 57 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.67870978 |
| 58 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.67008594 |
| 59 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.65516328 |
| 60 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.65043951 |
| 61 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.64939978 |
| 62 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.60848018 |
| 63 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60075348 |
| 64 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.55818925 |
| 65 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.54400368 |
| 66 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.53388210 |
| 67 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.52852369 |
| 68 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.49223177 |
| 69 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.48330238 |
| 70 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.47600987 |
| 71 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.45002883 |
| 72 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.44350868 |
| 73 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.44073225 |
| 74 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.43953007 |
| 75 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.42108704 |
| 76 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.40561599 |
| 77 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.40488000 |
| 78 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38627438 |
| 79 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.38095743 |
| 80 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.38095743 |
| 81 | * MYB_26560356_Chip-Seq_TH2_Human | 1.36860989 |
| 82 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.34613402 |
| 83 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.33172542 |
| 84 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32330256 |
| 85 | SPI1_23127762_ChIP-Seq_K562_Human | 1.31926328 |
| 86 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.31577524 |
| 87 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.29645493 |
| 88 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29114140 |
| 89 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.27806192 |
| 90 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.26649736 |
| 91 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.26396001 |
| 92 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25818192 |
| 93 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24908663 |
| 94 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.24509509 |
| 95 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24491858 |
| 96 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.23285309 |
| 97 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22612043 |
| 98 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.22257092 |
| 99 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.22206289 |
| 100 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.21961295 |
| 101 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.21852930 |
| 102 | MAF_26560356_Chip-Seq_TH2_Human | 1.21298246 |
| 103 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.20312799 |
| 104 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.18904397 |
| 105 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18394251 |
| 106 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.17657974 |
| 107 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.16575994 |
| 108 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16372003 |
| 109 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14704596 |
| 110 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14289729 |
| 111 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.11262195 |
| 112 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.10942989 |
| 113 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.10925762 |
| 114 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.10873516 |
| 115 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09310368 |
| 116 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.07899002 |
| 117 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.07205013 |
| 118 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.06249972 |
| 119 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.05849931 |
| 120 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.05820600 |
| 121 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.05723564 |
| 122 | GATA1_19941826_ChIP-Seq_K562_Human | 1.04922949 |
| 123 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04552193 |
| 124 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.03941124 |
| 125 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03194825 |
| 126 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.02966351 |
| 127 | P68_20966046_ChIP-Seq_HELA_Human | 1.02350291 |
| 128 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.02044399 |
| 129 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.02011916 |
| 130 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.01057480 |
| 131 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.00510986 |
| 132 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.99642403 |
| 133 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99552753 |
| 134 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99322987 |
| 135 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.99145553 |
| 136 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98184952 |
| 137 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.97530446 |
| 138 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.97055319 |
| 139 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.96684135 |
| 140 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.96308050 |
| 141 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.96192652 |
| 142 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.95752200 |
| 143 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.93985072 |
| 144 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.93421910 |
| 145 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.93094652 |
| 146 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92851548 |
| 147 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.91578177 |
| 148 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.91459519 |
| 149 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.91334300 |
| 150 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.90901816 |
| 151 | MYB_26560356_Chip-Seq_TH1_Human | 0.90767103 |
| 152 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.90520772 |
| 153 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.90436690 |
| 154 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.90184076 |
| 155 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88478251 |
| 156 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84977796 |
| 157 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.83225288 |
| 158 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82767350 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.66382255 |
| 2 | MP0003635_abnormal_synaptic_transmissio | 3.98973313 |
| 3 | MP0003436_decreased_susceptibility_to | 3.92688805 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.71666215 |
| 5 | MP0003724_increased_susceptibility_to | 3.54034593 |
| 6 | MP0003880_abnormal_central_pattern | 3.41717080 |
| 7 | MP0001790_abnormal_immune_system | 3.26136521 |
| 8 | MP0005387_immune_system_phenotype | 3.26136521 |
| 9 | MP0005000_abnormal_immune_tolerance | 3.15026128 |
| 10 | MP0002063_abnormal_learning/memory/cond | 3.14138475 |
| 11 | MP0009745_abnormal_behavioral_response | 2.95388603 |
| 12 | MP0002723_abnormal_immune_serum | 2.88155060 |
| 13 | MP0005025_abnormal_response_to | 2.84901110 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.77071527 |
| 15 | MP0002419_abnormal_innate_immunity | 2.74634928 |
| 16 | MP0002064_seizures | 2.74494353 |
| 17 | MP0003763_abnormal_thymus_physiology | 2.58718932 |
| 18 | MP0004270_analgesia | 2.52736487 |
| 19 | MP0009785_altered_susceptibility_to | 2.41948558 |
| 20 | MP0002572_abnormal_emotion/affect_behav | 2.40790493 |
| 21 | MP0009278_abnormal_bone_marrow | 2.32887937 |
| 22 | MP0000703_abnormal_thymus_morphology | 2.26448010 |
| 23 | MP0005423_abnormal_somatic_nervous | 2.22609945 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 2.22363188 |
| 25 | MP0006082_CNS_inflammation | 2.21131684 |
| 26 | MP0001968_abnormal_touch/_nociception | 2.13812584 |
| 27 | MP0008569_lethality_at_weaning | 2.09467090 |
| 28 | MP0002822_catalepsy | 2.06804633 |
| 29 | MP0005464_abnormal_platelet_physiology | 2.00154252 |
| 30 | MP0009046_muscle_twitch | 1.98879782 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.94266251 |
| 32 | MP0004947_skin_inflammation | 1.93003774 |
| 33 | MP0000465_gastrointestinal_hemorrhage | 1.90682578 |
| 34 | MP0003183_abnormal_peptide_metabolism | 1.90293874 |
| 35 | MP0004811_abnormal_neuron_physiology | 1.83037477 |
| 36 | MP0001873_stomach_inflammation | 1.82016921 |
| 37 | MP0002733_abnormal_thermal_nociception | 1.78935077 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.75878160 |
| 39 | MP0001533_abnormal_skeleton_physiology | 1.75830307 |
| 40 | MP0002272_abnormal_nervous_system | 1.74557605 |
| 41 | MP0003329_amyloid_beta_deposits | 1.73987892 |
| 42 | MP0004381_abnormal_hair_follicle | 1.71680082 |
| 43 | MP0003787_abnormal_imprinting | 1.68168284 |
| 44 | MP0001970_abnormal_pain_threshold | 1.67548734 |
| 45 | MP0001486_abnormal_startle_reflex | 1.62286572 |
| 46 | MP0002735_abnormal_chemical_nociception | 1.56947912 |
| 47 | MP0005386_behavior/neurological_phenoty | 1.56806857 |
| 48 | MP0004924_abnormal_behavior | 1.56806857 |
| 49 | MP0003303_peritoneal_inflammation | 1.54821828 |
| 50 | MP0005076_abnormal_cell_differentiation | 1.51325628 |
| 51 | MP0008961_abnormal_basal_metabolism | 1.46814550 |
| 52 | MP0008260_abnormal_autophagy | 1.46684709 |
| 53 | MP0002132_abnormal_respiratory_system | 1.45235949 |
| 54 | MP0002398_abnormal_bone_marrow | 1.44925444 |
| 55 | MP0004858_abnormal_nervous_system | 1.42927862 |
| 56 | MP0002734_abnormal_mechanical_nocicepti | 1.42278816 |
| 57 | MP0001851_eye_inflammation | 1.40406031 |
| 58 | MP0005409_darkened_coat_color | 1.39763024 |
| 59 | MP0002736_abnormal_nociception_after | 1.38488079 |
| 60 | MP0000778_abnormal_nervous_system | 1.37912759 |
| 61 | MP0008877_abnormal_DNA_methylation | 1.37068347 |
| 62 | MP0005397_hematopoietic_system_phenotyp | 1.35650590 |
| 63 | MP0001545_abnormal_hematopoietic_system | 1.35650590 |
| 64 | MP0002009_preneoplasia | 1.34991667 |
| 65 | MP0002396_abnormal_hematopoietic_system | 1.34710211 |
| 66 | MP0008469_abnormal_protein_level | 1.33770131 |
| 67 | MP0003866_abnormal_defecation | 1.33286973 |
| 68 | MP0005645_abnormal_hypothalamus_physiol | 1.33280287 |
| 69 | MP0002557_abnormal_social/conspecific_i | 1.32448101 |
| 70 | MP0002067_abnormal_sensory_capabilities | 1.32432200 |
| 71 | MP0002277_abnormal_respiratory_mucosa | 1.32058448 |
| 72 | MP0002184_abnormal_innervation | 1.31740595 |
| 73 | MP0008874_decreased_physiological_sensi | 1.30027998 |
| 74 | MP0000955_abnormal_spinal_cord | 1.28539931 |
| 75 | MP0003633_abnormal_nervous_system | 1.27482704 |
| 76 | MP0000490_abnormal_crypts_of | 1.27288040 |
| 77 | MP0005451_abnormal_body_composition | 1.26296083 |
| 78 | MP0004510_myositis | 1.23947222 |
| 79 | MP0002909_abnormal_adrenal_gland | 1.22293543 |
| 80 | MP0003191_abnormal_cellular_cholesterol | 1.18871763 |
| 81 | MP0009780_abnormal_chondrocyte_physiolo | 1.18589998 |
| 82 | MP0002722_abnormal_immune_system | 1.18485556 |
| 83 | MP0005174_abnormal_tail_pigmentation | 1.18374826 |
| 84 | MP0003879_abnormal_hair_cell | 1.17284106 |
| 85 | MP0001440_abnormal_grooming_behavior | 1.16976863 |
| 86 | MP0000685_abnormal_immune_system | 1.16963475 |
| 87 | MP0005075_abnormal_melanosome_morpholog | 1.16810000 |
| 88 | MP0001501_abnormal_sleep_pattern | 1.16059486 |
| 89 | MP0002066_abnormal_motor_capabilities/c | 1.15721960 |
| 90 | MP0003075_altered_response_to | 1.14444111 |
| 91 | MP0000858_altered_metastatic_potential | 1.13523308 |
| 92 | MP0002933_joint_inflammation | 1.11768541 |
| 93 | MP0005671_abnormal_response_to | 1.10790252 |
| 94 | MP0003172_abnormal_lysosome_physiology | 1.09849829 |
| 95 | MP0008770_decreased_survivor_rate | 1.08755903 |
| 96 | MP0000015_abnormal_ear_pigmentation | 1.08465882 |
| 97 | MP0002882_abnormal_neuron_morphology | 1.06069307 |
| 98 | MP0002998_abnormal_bone_remodeling | 1.04795158 |
| 99 | MP0000716_abnormal_immune_system | 1.03024626 |
| 100 | MP0002152_abnormal_brain_morphology | 1.02492853 |
| 101 | MP0003828_pulmonary_edema | 1.02364693 |
| 102 | MP0003631_nervous_system_phenotype | 1.01309194 |
| 103 | MP0002138_abnormal_hepatobiliary_system | 1.01227526 |
| 104 | MP0000013_abnormal_adipose_tissue | 1.00504397 |
| 105 | MP0010234_abnormal_vibrissa_follicle | 1.00397484 |
| 106 | MP0004808_abnormal_hematopoietic_stem | 0.99219941 |
| 107 | MP0002166_altered_tumor_susceptibility | 0.95686352 |
| 108 | MP0008872_abnormal_physiological_respon | 0.95358161 |
| 109 | MP0005058_abnormal_lysosome_morphology | 0.94768021 |
| 110 | MP0001663_abnormal_digestive_system | 0.92635982 |
| 111 | MP0010094_abnormal_chromosome_stability | 0.92333398 |
| 112 | MP0004883_abnormal_blood_vessel | 0.90881533 |
| 113 | MP0002163_abnormal_gland_morphology | 0.88933225 |
| 114 | MP0010352_gastrointestinal_tract_polyps | 0.88001911 |
| 115 | MP0000689_abnormal_spleen_morphology | 0.87749182 |
| 116 | MP0002006_tumorigenesis | 0.87549536 |
| 117 | MP0001529_abnormal_vocalization | 0.83996831 |
| 118 | MP0009333_abnormal_splenocyte_physiolog | 0.82532128 |
| 119 | MP0004130_abnormal_muscle_cell | 0.82472516 |
| 120 | MP0002420_abnormal_adaptive_immunity | 0.82443649 |
| 121 | MP0009764_decreased_sensitivity_to | 0.80825859 |
| 122 | MP0001819_abnormal_immune_cell | 0.80229537 |
| 123 | MP0002405_respiratory_system_inflammati | 0.79995363 |
| 124 | MP0001853_heart_inflammation | 0.79872656 |
| 125 | MP0005310_abnormal_salivary_gland | 0.79689817 |
| 126 | MP0005394_taste/olfaction_phenotype | 0.79267741 |
| 127 | MP0005499_abnormal_olfactory_system | 0.79267741 |
| 128 | MP0010769_abnormal_survival | 0.78845149 |
| 129 | MP0003091_abnormal_cell_migration | 0.78471503 |
| 130 | MP0005390_skeleton_phenotype | 0.77693653 |
| 131 | MP0003045_fibrosis | 0.76287033 |
| 132 | MP0010768_mortality/aging | 0.75828477 |
| 133 | MP0002069_abnormal_eating/drinking_beha | 0.75542260 |
| 134 | MP0004885_abnormal_endolymph | 0.75126461 |
| 135 | MP0002429_abnormal_blood_cell | 0.75093064 |
| 136 | MP0005166_decreased_susceptibility_to | 0.74335709 |
| 137 | MP0002928_abnormal_bile_duct | 0.73337424 |
| 138 | MP0001905_abnormal_dopamine_level | 0.73121396 |
| 139 | MP0002083_premature_death | 0.71333815 |
| 140 | MP0009763_increased_sensitivity_to | 0.71250626 |
| 141 | MP0010770_preweaning_lethality | 0.70427033 |
| 142 | MP0002082_postnatal_lethality | 0.70427033 |
| 143 | MP0008057_abnormal_DNA_replication | 0.69820120 |
| 144 | MP0001849_ear_inflammation | 0.69043806 |
| 145 | MP0001348_abnormal_lacrimal_gland | 0.68313948 |
| 146 | MP0002019_abnormal_tumor_incidence | 0.67760366 |
| 147 | MP0003861_abnormal_nervous_system | 0.67488240 |
| 148 | MP0010155_abnormal_intestine_physiology | 0.66835757 |
| 149 | MP0001800_abnormal_humoral_immune | 0.66334491 |
| 150 | MP0003448_altered_tumor_morphology | 0.65265173 |
| 151 | MP0000249_abnormal_blood_vessel | 0.62771973 |
| 152 | MP0002653_abnormal_ependyma_morphology | 0.60180496 |
| 153 | MP0001986_abnormal_taste_sensitivity | 0.58777657 |
| 154 | MP0005164_abnormal_response_to | 0.55773595 |
| 155 | MP0000604_amyloidosis | 0.55703899 |
| 156 | MP0002693_abnormal_pancreas_physiology | 0.55230017 |
| 157 | MP0003795_abnormal_bone_structure | 0.54285848 |
| 158 | MP0005381_digestive/alimentary_phenotyp | 0.51605395 |
| 159 | MP0009765_abnormal_xenobiotic_induced | 0.46308943 |
| 160 | MP0003690_abnormal_glial_cell | 0.45685313 |
| 161 | MP0002133_abnormal_respiratory_system | 0.44301066 |
| 162 | MP0005388_respiratory_system_phenotype | 0.44301066 |
| 163 | MP0005377_hearing/vestibular/ear_phenot | 0.42888751 |
| 164 | MP0003878_abnormal_ear_physiology | 0.42888751 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.76364106 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.89650095 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.67782037 |
| 4 | Myositis (HP:0100614) | 5.15689938 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.07964818 |
| 6 | Myokymia (HP:0002411) | 4.97890639 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.85102946 |
| 8 | Stomatitis (HP:0010280) | 4.80422193 |
| 9 | Focal motor seizures (HP:0011153) | 4.72535545 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.44087229 |
| 11 | Meningitis (HP:0001287) | 4.42801267 |
| 12 | Visual hallucinations (HP:0002367) | 4.41401394 |
| 13 | T lymphocytopenia (HP:0005403) | 4.20207690 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 4.18608011 |
| 15 | Orchitis (HP:0100796) | 4.04862897 |
| 16 | Gastrointestinal infarctions (HP:0005244) | 4.03145757 |
| 17 | Vasculitis (HP:0002633) | 3.92792429 |
| 18 | Retrobulbar optic neuritis (HP:0100654) | 3.92650228 |
| 19 | Optic neuritis (HP:0100653) | 3.92650228 |
| 20 | Abnormality of T cell number (HP:0011839) | 3.85703570 |
| 21 | Gastrointestinal stroma tumor (HP:0100723) | 3.83481598 |
| 22 | Chronic obstructive pulmonary disease (HP:0006510) | 3.82446106 |
| 23 | Obstructive lung disease (HP:0006536) | 3.82446106 |
| 24 | Recurrent skin infections (HP:0001581) | 3.82063779 |
| 25 | Lymphopenia (HP:0001888) | 3.78753426 |
| 26 | Pustule (HP:0200039) | 3.77907413 |
| 27 | Increased IgE level (HP:0003212) | 3.76084385 |
| 28 | Papilledema (HP:0001085) | 3.73825444 |
| 29 | Focal seizures (HP:0007359) | 3.68986660 |
| 30 | IgM deficiency (HP:0002850) | 3.53162048 |
| 31 | Encephalitis (HP:0002383) | 3.52757302 |
| 32 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.51098865 |
| 33 | Cellulitis (HP:0100658) | 3.49795877 |
| 34 | Urticaria (HP:0001025) | 3.49413627 |
| 35 | Petechiae (HP:0000967) | 3.47159804 |
| 36 | Agammaglobulinemia (HP:0004432) | 3.43913980 |
| 37 | Dysmetric saccades (HP:0000641) | 3.41765638 |
| 38 | Spontaneous hematomas (HP:0007420) | 3.40294943 |
| 39 | Annular pancreas (HP:0001734) | 3.39388067 |
| 40 | Recurrent cutaneous fungal infections (HP:0011370) | 3.34391732 |
| 41 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.34391732 |
| 42 | Abnormality of B cell number (HP:0010975) | 3.29344101 |
| 43 | B lymphocytopenia (HP:0010976) | 3.29344101 |
| 44 | Recurrent bronchitis (HP:0002837) | 3.28528669 |
| 45 | Chest pain (HP:0100749) | 3.27923713 |
| 46 | Panhypogammaglobulinemia (HP:0003139) | 3.25733626 |
| 47 | Prolonged bleeding time (HP:0003010) | 3.20967704 |
| 48 | Inflammation of the large intestine (HP:0002037) | 3.17546746 |
| 49 | Abnormality of T cell physiology (HP:0011840) | 3.15924525 |
| 50 | Abnormality of the lower motor neuron (HP:0002366) | 3.13506327 |
| 51 | Gastrointestinal inflammation (HP:0004386) | 3.12679846 |
| 52 | Thyroiditis (HP:0100646) | 3.09823476 |
| 53 | Supranuclear gaze palsy (HP:0000605) | 3.08543097 |
| 54 | Severe combined immunodeficiency (HP:0004430) | 3.07562568 |
| 55 | Amyotrophic lateral sclerosis (HP:0007354) | 3.06097372 |
| 56 | Recurrent sinusitis (HP:0011108) | 3.02906916 |
| 57 | Pulmonary infiltrates (HP:0002113) | 3.01174879 |
| 58 | Purpura (HP:0000979) | 2.96868950 |
| 59 | Gingivitis (HP:0000230) | 2.96761387 |
| 60 | Increased IgM level (HP:0003496) | 2.95205297 |
| 61 | Hyperacusis (HP:0010780) | 2.90535183 |
| 62 | Impaired smooth pursuit (HP:0007772) | 2.88762408 |
| 63 | Hypochromic anemia (HP:0001931) | 2.85201790 |
| 64 | Keratoconjunctivitis sicca (HP:0001097) | 2.83910415 |
| 65 | Truncal ataxia (HP:0002078) | 2.82128332 |
| 66 | Epileptic encephalopathy (HP:0200134) | 2.80721017 |
| 67 | Colitis (HP:0002583) | 2.79774807 |
| 68 | Epistaxis (HP:0000421) | 2.79085817 |
| 69 | Eosinophilia (HP:0001880) | 2.78287174 |
| 70 | Hemiplegia (HP:0002301) | 2.78214350 |
| 71 | Absence seizures (HP:0002121) | 2.77488561 |
| 72 | IgG deficiency (HP:0004315) | 2.75329178 |
| 73 | Pointed chin (HP:0000307) | 2.74369148 |
| 74 | Autoimmune hemolytic anemia (HP:0001890) | 2.73793559 |
| 75 | Leukocytosis (HP:0001974) | 2.72052758 |
| 76 | Combined immunodeficiency (HP:0005387) | 2.71781594 |
| 77 | Recurrent viral infections (HP:0004429) | 2.66995912 |
| 78 | Hypochromic microcytic anemia (HP:0004840) | 2.66712808 |
| 79 | Depression (HP:0000716) | 2.66690990 |
| 80 | Atonic seizures (HP:0010819) | 2.65670316 |
| 81 | Gingival bleeding (HP:0000225) | 2.63472562 |
| 82 | Keratoconjunctivitis (HP:0001096) | 2.63076414 |
| 83 | Obstructive sleep apnea (HP:0002870) | 2.58327306 |
| 84 | Sepsis (HP:0100806) | 2.56823574 |
| 85 | Osteomyelitis (HP:0002754) | 2.55838096 |
| 86 | Poor eye contact (HP:0000817) | 2.55648490 |
| 87 | Ankyloglossia (HP:0010296) | 2.53683016 |
| 88 | Insomnia (HP:0100785) | 2.53196933 |
| 89 | Urinary urgency (HP:0000012) | 2.52207318 |
| 90 | Broad-based gait (HP:0002136) | 2.50195643 |
| 91 | Macroorchidism (HP:0000053) | 2.49293940 |
| 92 | Chronic diarrhea (HP:0002028) | 2.48899135 |
| 93 | Hypergammaglobulinemia (HP:0010702) | 2.47550095 |
| 94 | Volvulus (HP:0002580) | 2.45828442 |
| 95 | Hemoptysis (HP:0002105) | 2.45043616 |
| 96 | Hypoplasia of the thymus (HP:0000778) | 2.44408823 |
| 97 | Impaired social interactions (HP:0000735) | 2.44399541 |
| 98 | Abnormal social behavior (HP:0012433) | 2.44399541 |
| 99 | Episodic fever (HP:0001954) | 2.40879684 |
| 100 | Hyperventilation (HP:0002883) | 2.39281922 |
| 101 | Hypercortisolism (HP:0001578) | 2.38328890 |
| 102 | Emphysema (HP:0002097) | 2.38022911 |
| 103 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.37750192 |
| 104 | Stereotypic behavior (HP:0000733) | 2.36348484 |
| 105 | Restrictive lung disease (HP:0002091) | 2.36199909 |
| 106 | Abnormality of T cells (HP:0002843) | 2.35052721 |
| 107 | Ankle clonus (HP:0011448) | 2.34901309 |
| 108 | Abnormality of the corticospinal tract (HP:0002492) | 2.32385952 |
| 109 | Recurrent pneumonia (HP:0006532) | 2.31860220 |
| 110 | Dialeptic seizures (HP:0011146) | 2.31736380 |
| 111 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.30945259 |
| 112 | Abnormality of binocular vision (HP:0011514) | 2.29296675 |
| 113 | Diplopia (HP:0000651) | 2.29296675 |
| 114 | Arterial thrombosis (HP:0004420) | 2.29224382 |
| 115 | Cerebral inclusion bodies (HP:0100314) | 2.28533242 |
| 116 | Papilloma (HP:0012740) | 2.26198799 |
| 117 | Verrucae (HP:0200043) | 2.26198799 |
| 118 | Premature loss of primary teeth (HP:0006323) | 2.25847829 |
| 119 | Pulmonary embolism (HP:0002204) | 2.25832046 |
| 120 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.24310176 |
| 121 | Slow saccadic eye movements (HP:0000514) | 2.22720514 |
| 122 | Skin ulcer (HP:0200042) | 2.22613487 |
| 123 | Action tremor (HP:0002345) | 2.22209842 |
| 124 | Recurrent fungal infections (HP:0002841) | 2.22181691 |
| 125 | Acute hepatic failure (HP:0006554) | 2.18791116 |
| 126 | Spastic gait (HP:0002064) | 2.18166279 |
| 127 | Abnormality of oral frenula (HP:0000190) | 2.17959526 |
| 128 | Abnormal platelet volume (HP:0011876) | 2.15500993 |
| 129 | Chronic otitis media (HP:0000389) | 2.15052330 |
| 130 | Abnormality of the pleura (HP:0002103) | 2.14860537 |
| 131 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.14838142 |
| 132 | Arthralgia (HP:0002829) | 2.14435535 |
| 133 | Recurrent lower respiratory tract infections (HP:0002783) | 2.14401772 |
| 134 | Skin rash (HP:0000988) | 2.12190457 |
| 135 | Granulocytopenia (HP:0001913) | 2.11481769 |
| 136 | Joint swelling (HP:0001386) | 2.10866130 |
| 137 | Abnormality of eosinophils (HP:0001879) | 2.08215630 |
| 138 | Anxiety (HP:0000739) | 2.08148314 |
| 139 | Apathy (HP:0000741) | 2.05722648 |
| 140 | Microcytic anemia (HP:0001935) | 2.03497651 |
| 141 | Anorexia (HP:0002039) | 2.02419412 |
| 142 | Lymphoma (HP:0002665) | 2.01325759 |
| 143 | Febrile seizures (HP:0002373) | 2.01232184 |
| 144 | Pseudobulbar signs (HP:0002200) | 1.99711514 |
| 145 | Mutism (HP:0002300) | 1.98691172 |
| 146 | Abnormality of the fingertips (HP:0001211) | 1.96753293 |
| 147 | Nasal polyposis (HP:0100582) | 1.96696403 |
| 148 | Basal cell carcinoma (HP:0002671) | 1.95783863 |
| 149 | Insidious onset (HP:0003587) | 1.94496781 |
| 150 | Termporal pattern (HP:0011008) | 1.94496781 |
| 151 | IgA deficiency (HP:0002720) | 1.94039390 |
| 152 | Amyloidosis (HP:0011034) | 1.94034696 |
| 153 | Gaze-evoked nystagmus (HP:0000640) | 1.91746039 |
| 154 | Viral hepatitis (HP:0006562) | 1.91720076 |
| 155 | Generalized tonic-clonic seizures (HP:0002069) | 1.91041203 |
| 156 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.89059835 |
| 157 | Deep palmar crease (HP:0006191) | 1.87472914 |
| 158 | Dysmetria (HP:0001310) | 1.85374052 |
| 159 | Hypoproteinemia (HP:0003075) | 1.84670127 |
| 160 | Torticollis (HP:0000473) | 1.84190931 |
| 161 | Progressive cerebellar ataxia (HP:0002073) | 1.83047668 |
| 162 | Diminished motivation (HP:0000745) | 1.80743762 |
| 163 | Menstrual irregularities (HP:0000858) | 1.80088127 |
| 164 | Inappropriate behavior (HP:0000719) | 1.79927752 |
| 165 | Drooling (HP:0002307) | 1.79030570 |
| 166 | Excessive salivation (HP:0003781) | 1.79030570 |
| 167 | Large eyes (HP:0001090) | 1.78951250 |
| 168 | Focal dystonia (HP:0004373) | 1.78806473 |
| 169 | Elfin facies (HP:0004428) | 1.78263616 |
| 170 | Acute lymphatic leukemia (HP:0006721) | 1.78256698 |
| 171 | Obsessive-compulsive behavior (HP:0000722) | 1.76952555 |
| 172 | Dysdiadochokinesis (HP:0002075) | 1.75976548 |
| 173 | Postural instability (HP:0002172) | 1.74902067 |
| 174 | Genetic anticipation (HP:0003743) | 1.74550571 |
| 175 | Sacral dimple (HP:0000960) | 1.73895310 |
| 176 | Lower limb asymmetry (HP:0100559) | 1.73256834 |
| 177 | Increased nuchal translucency (HP:0010880) | 1.72853478 |
| 178 | Open mouth (HP:0000194) | 1.72597335 |
| 179 | Megalencephaly (HP:0001355) | 1.71773220 |
| 180 | Abnormal eating behavior (HP:0100738) | 1.69789913 |
| 181 | Thickened helices (HP:0000391) | 1.68442571 |
| 182 | Neurofibrillary tangles (HP:0002185) | 1.68175863 |
| 183 | Abnormality of the periventricular white matter (HP:0002518) | 1.67589572 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EEF2K | 4.19219578 |
| 2 | BLK | 3.33303291 |
| 3 | MAP3K10 | 3.08318977 |
| 4 | MARK1 | 2.85186850 |
| 5 | MAP3K9 | 2.84399591 |
| 6 | IRAK4 | 2.67204497 |
| 7 | TRIB3 | 2.64680873 |
| 8 | EPHA4 | 2.56374434 |
| 9 | TYK2 | 2.52289004 |
| 10 | ERN1 | 2.33340042 |
| 11 | GRK6 | 2.28857676 |
| 12 | NTRK3 | 2.25735070 |
| 13 | ICK | 2.17749745 |
| 14 | BTK | 2.16352082 |
| 15 | PKN2 | 2.14325834 |
| 16 | IKBKE | 2.03125745 |
| 17 | JAK3 | 1.98777832 |
| 18 | UHMK1 | 1.95568069 |
| 19 | SIK3 | 1.95221406 |
| 20 | NTRK2 | 1.94974113 |
| 21 | MINK1 | 1.93613628 |
| 22 | MAP4K1 | 1.92093292 |
| 23 | SIK2 | 1.92081352 |
| 24 | DAPK1 | 1.85982070 |
| 25 | FES | 1.83890012 |
| 26 | MAP3K14 | 1.78591876 |
| 27 | PASK | 1.76063139 |
| 28 | PAK6 | 1.73571275 |
| 29 | TYRO3 | 1.73032155 |
| 30 | TBK1 | 1.70274554 |
| 31 | MAP3K7 | 1.68785738 |
| 32 | SMG1 | 1.63017707 |
| 33 | TAOK3 | 1.62441954 |
| 34 | CDK19 | 1.58208675 |
| 35 | MAP2K3 | 1.56184999 |
| 36 | CAMKK1 | 1.54605639 |
| 37 | EPHB1 | 1.53311023 |
| 38 | LYN | 1.53006862 |
| 39 | ITK | 1.52917477 |
| 40 | SCYL2 | 1.50193804 |
| 41 | ALK | 1.49671835 |
| 42 | PRKCH | 1.48192344 |
| 43 | DAPK2 | 1.46448204 |
| 44 | KSR2 | 1.46398251 |
| 45 | RIPK4 | 1.42256120 |
| 46 | JAK1 | 1.41904183 |
| 47 | MAP3K4 | 1.39939399 |
| 48 | CSF1R | 1.35321896 |
| 49 | TNK2 | 1.32024101 |
| 50 | PRPF4B | 1.31449431 |
| 51 | JAK2 | 1.26091068 |
| 52 | CDK5 | 1.23034102 |
| 53 | MARK3 | 1.22571484 |
| 54 | TAOK1 | 1.21898291 |
| 55 | KSR1 | 1.17199151 |
| 56 | SYK | 1.12331059 |
| 57 | HIPK2 | 1.10628918 |
| 58 | TEC | 1.09438537 |
| 59 | PRKD3 | 1.07103109 |
| 60 | MARK2 | 1.04913858 |
| 61 | IKBKB | 1.02932351 |
| 62 | RAF1 | 0.99173133 |
| 63 | CDK15 | 0.95105528 |
| 64 | MAPK7 | 0.94698190 |
| 65 | CDK18 | 0.93563305 |
| 66 | FGFR4 | 0.92647744 |
| 67 | FGR | 0.92594534 |
| 68 | PIM1 | 0.91688012 |
| 69 | MAP3K3 | 0.89147658 |
| 70 | CDK11A | 0.88320125 |
| 71 | MAPK13 | 0.87103087 |
| 72 | KIT | 0.86930832 |
| 73 | PDGFRB | 0.85595355 |
| 74 | CDC7 | 0.85264425 |
| 75 | LRRK2 | 0.85061286 |
| 76 | CSK | 0.84536598 |
| 77 | TLK1 | 0.83226549 |
| 78 | PDK1 | 0.81853183 |
| 79 | MAP3K13 | 0.81606336 |
| 80 | CDK14 | 0.79630872 |
| 81 | CLK1 | 0.78127825 |
| 82 | ZAP70 | 0.78031979 |
| 83 | RPS6KB2 | 0.76813535 |
| 84 | RET | 0.72094252 |
| 85 | BMX | 0.69981292 |
| 86 | SGK3 | 0.68453866 |
| 87 | MAP3K6 | 0.68437781 |
| 88 | ILK | 0.67420908 |
| 89 | NTRK1 | 0.66884585 |
| 90 | SIK1 | 0.66133410 |
| 91 | NLK | 0.65683899 |
| 92 | MAPK4 | 0.64647224 |
| 93 | MAP3K11 | 0.64177804 |
| 94 | PTK6 | 0.62191964 |
| 95 | DMPK | 0.60075704 |
| 96 | NEK1 | 0.58680843 |
| 97 | MAPK12 | 0.58512037 |
| 98 | MAP2K7 | 0.58230890 |
| 99 | CAMK1 | 0.56485149 |
| 100 | FGFR3 | 0.56032112 |
| 101 | CDK12 | 0.55801730 |
| 102 | MAPK11 | 0.55506151 |
| 103 | TXK | 0.54905053 |
| 104 | TAOK2 | 0.54553092 |
| 105 | PRKCG | 0.54461947 |
| 106 | BRSK1 | 0.54307900 |
| 107 | PDGFRA | 0.54225303 |
| 108 | MAP3K2 | 0.53576419 |
| 109 | FYN | 0.53269587 |
| 110 | STK11 | 0.53244041 |
| 111 | MAP3K12 | 0.52631558 |
| 112 | STK10 | 0.51217787 |
| 113 | HCK | 0.50473828 |
| 114 | TESK2 | 0.50296175 |
| 115 | NEK2 | 0.48424828 |
| 116 | TGFBR2 | 0.47722026 |
| 117 | FGFR2 | 0.47089239 |
| 118 | CDK6 | 0.46951964 |
| 119 | PDPK1 | 0.46882011 |
| 120 | CSNK1G2 | 0.45708357 |
| 121 | CAMKK2 | 0.45315630 |
| 122 | MOS | 0.45273937 |
| 123 | PRKD2 | 0.43093040 |
| 124 | PTK2B | 0.42880465 |
| 125 | EPHA3 | 0.42617273 |
| 126 | BMPR2 | 0.42268189 |
| 127 | MAP2K4 | 0.42198919 |
| 128 | MAP3K1 | 0.41165662 |
| 129 | MAPKAPK2 | 0.40766800 |
| 130 | LCK | 0.40226394 |
| 131 | PRKCQ | 0.39470030 |
| 132 | PHKG2 | 0.39449342 |
| 133 | PHKG1 | 0.39449342 |
| 134 | SGK1 | 0.39322863 |
| 135 | PLK2 | 0.39223281 |
| 136 | MAPK9 | 0.38052175 |
| 137 | TNIK | 0.37803053 |
| 138 | DYRK1B | 0.37701523 |
| 139 | YES1 | 0.37320340 |
| 140 | RPS6KC1 | 0.36846542 |
| 141 | RPS6KL1 | 0.36846542 |
| 142 | MAPK8 | 0.36201503 |
| 143 | CDK4 | 0.35850280 |
| 144 | DAPK3 | 0.34941505 |
| 145 | IRAK1 | 0.34672673 |
| 146 | GRK7 | 0.34033386 |
| 147 | MAP3K8 | 0.33473118 |
| 148 | KDR | 0.32518322 |
| 149 | CDC42BPA | 0.32083964 |
| 150 | RPS6KA6 | 0.30754756 |
| 151 | VRK1 | 0.29956844 |
| 152 | STK4 | 0.28239194 |
| 153 | STK38 | 0.28154989 |
| 154 | IRAK2 | 0.27991549 |
| 155 | RPS6KA5 | 0.27183683 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.34717670 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.20361349 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.16384482 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.71547601 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.53800026 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.47176016 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.42993843 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.28592032 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.18962796 |
| 10 | Nicotine addiction_Homo sapiens_hsa05033 | 2.12604850 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.10835527 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.05833182 |
| 13 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.05068410 |
| 14 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.02405066 |
| 15 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.97855178 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.95658553 |
| 17 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.93367066 |
| 18 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.92785412 |
| 19 | Circadian entrainment_Homo sapiens_hsa04713 | 1.91498885 |
| 20 | Morphine addiction_Homo sapiens_hsa05032 | 1.90084569 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.89375422 |
| 22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.89279519 |
| 23 | GABAergic synapse_Homo sapiens_hsa04727 | 1.87654689 |
| 24 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.85438344 |
| 25 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.84040209 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.82059536 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.81757695 |
| 28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.78860177 |
| 29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.78517625 |
| 30 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.74690537 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.70088799 |
| 32 | Glioma_Homo sapiens_hsa05214 | 1.65923896 |
| 33 | Salivary secretion_Homo sapiens_hsa04970 | 1.65914055 |
| 34 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.65083859 |
| 35 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.57257919 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.56960639 |
| 37 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.56801066 |
| 38 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.54537367 |
| 39 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.50359298 |
| 40 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.49045493 |
| 41 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.47820394 |
| 42 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.46370083 |
| 43 | Colorectal cancer_Homo sapiens_hsa05210 | 1.45948164 |
| 44 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44450002 |
| 45 | Influenza A_Homo sapiens_hsa05164 | 1.41203853 |
| 46 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.40505987 |
| 47 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.36977072 |
| 48 | Renin secretion_Homo sapiens_hsa04924 | 1.34992477 |
| 49 | Gap junction_Homo sapiens_hsa04540 | 1.34188019 |
| 50 | Endometrial cancer_Homo sapiens_hsa05213 | 1.33864453 |
| 51 | Long-term depression_Homo sapiens_hsa04730 | 1.31824054 |
| 52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.31261871 |
| 53 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.30617866 |
| 54 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.29743103 |
| 55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.29631242 |
| 56 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.28934399 |
| 57 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.27955476 |
| 58 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.27531532 |
| 59 | Malaria_Homo sapiens_hsa05144 | 1.27417700 |
| 60 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.23598537 |
| 61 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.22074482 |
| 62 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.19999153 |
| 63 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.19890252 |
| 64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.19114945 |
| 65 | Cocaine addiction_Homo sapiens_hsa05030 | 1.17784042 |
| 66 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.16863335 |
| 67 | Insulin secretion_Homo sapiens_hsa04911 | 1.16145785 |
| 68 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.16046646 |
| 69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.09809109 |
| 70 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.09217886 |
| 71 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.08678856 |
| 72 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.06953488 |
| 73 | Taste transduction_Homo sapiens_hsa04742 | 1.05786533 |
| 74 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.05748497 |
| 75 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.03481520 |
| 76 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.01068060 |
| 77 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.00928500 |
| 78 | Phagosome_Homo sapiens_hsa04145 | 1.00854999 |
| 79 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.00249581 |
| 80 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.97335308 |
| 81 | Melanogenesis_Homo sapiens_hsa04916 | 0.97272521 |
| 82 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.96113482 |
| 83 | Other glycan degradation_Homo sapiens_hsa00511 | 0.95692859 |
| 84 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.95285821 |
| 85 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.94126893 |
| 86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.93879006 |
| 87 | Axon guidance_Homo sapiens_hsa04360 | 0.93821001 |
| 88 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.93029593 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.92817769 |
| 90 | Apoptosis_Homo sapiens_hsa04210 | 0.92074107 |
| 91 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90778224 |
| 92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.90761887 |
| 93 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.90017699 |
| 94 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.88623370 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.88585618 |
| 96 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.88134584 |
| 97 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.88030193 |
| 98 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.87568380 |
| 99 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.87533401 |
| 100 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.86656558 |
| 101 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.84853631 |
| 102 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.84386575 |
| 103 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.82208480 |
| 104 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81524713 |
| 105 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80642894 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.79510263 |
| 107 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.78362622 |
| 108 | Legionellosis_Homo sapiens_hsa05134 | 0.78146763 |
| 109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.73405143 |
| 110 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.72791643 |
| 111 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.71506545 |
| 112 | Endocytosis_Homo sapiens_hsa04144 | 0.70060093 |
| 113 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.69964323 |
| 114 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67272853 |
| 115 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.66574364 |
| 116 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.66221441 |
| 117 | Platelet activation_Homo sapiens_hsa04611 | 0.64083185 |
| 118 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63186429 |
| 119 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62238976 |
| 120 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.61515490 |
| 121 | Alcoholism_Homo sapiens_hsa05034 | 0.61295183 |
| 122 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.60854572 |
| 123 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59859667 |
| 124 | Thyroid cancer_Homo sapiens_hsa05216 | 0.58289378 |
| 125 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57013900 |
| 126 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.56911355 |
| 127 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56637226 |
| 128 | Hepatitis B_Homo sapiens_hsa05161 | 0.56345771 |
| 129 | Pertussis_Homo sapiens_hsa05133 | 0.55474348 |
| 130 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54876359 |
| 131 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.54055144 |
| 132 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.53528125 |
| 133 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.52936766 |
| 134 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51356710 |
| 135 | Shigellosis_Homo sapiens_hsa05131 | 0.50458471 |
| 136 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.49987396 |
| 137 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.49701029 |
| 138 | Salmonella infection_Homo sapiens_hsa05132 | 0.47178805 |
| 139 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.47102171 |
| 140 | DNA replication_Homo sapiens_hsa03030 | 0.46941184 |
| 141 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46035232 |
| 142 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.45223930 |
| 143 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.44047927 |
| 144 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42779227 |
| 145 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42765469 |
| 146 | Prion diseases_Homo sapiens_hsa05020 | 0.42701441 |
| 147 | Viral myocarditis_Homo sapiens_hsa05416 | 0.41677729 |
| 148 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40193062 |
| 149 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.39362372 |
| 150 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36340161 |
| 151 | Prostate cancer_Homo sapiens_hsa05215 | 0.29677498 |
| 152 | Lysosome_Homo sapiens_hsa04142 | 0.29008830 |
| 153 | Insulin resistance_Homo sapiens_hsa04931 | 0.27002337 |
| 154 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.26195714 |
| 155 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.24787885 |
| 156 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.23979763 |

